Guanhao Biotech Co.,Ltd.

¥10.69As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300238Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (12.84%)
Div yield —
ROE 0.21%
Biotechnology
Beta (5Y) 0.27
PE TTM 212.0
TSR TTM (31.91%)
Mkt cap ¥2.936B
ROIC 0.29%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥11
0.85%
(62.37%)
Hold 7|10|12|2|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.15
0.15
0.15
0.16
(1.98%)
(7.83%)
(6.35%)
5.62%
Revenue¥M
145.4
145.6
143.9
146.2
6.14%
8.19%
6.59%
3.21%
Peers (US$440.2M)
Cap (US$)
PE
439.6M
29.51x
Capital
TTM
5Y
10Y
Leveragex
0.223
1.185
0.900
EBIT/Intx
0.398
0.296
0.254
Own earn%
0.91
(76.96)
(89.03)
Sh yield%
42.81
22.36
24.01
Owners
Insiders/Inst%
2.54
32.58
Short interest%
3.51
SBC / revenue%
3.38
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
13–30
$1 testx
0.1
Incr. ROIC%
12